4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-21-068849
Options or other derivatives
- Chief Financial Officer acquired 406,020 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Booth Andrew Chief Financial Officer | 2021-12-07 | Grant or award · Share Option (right to buy) | +406,020 | 5,884,820 | D | ||
Loading xslF345X03/doc4.xml…